Oligio Kiss: why radiofrequency and focused ultrasound were put in one machine
Radiofrequency and focused ultrasound are not rival answers to the same question. RF warms a broad volume of dermis; HIFU deposits discrete coagulation points at a set depth. They work on different tissue in different ways, which is why “which one is better” has no answer — and why some faces need both. That is the reasoning behind this device. This page sets out what Oligio Kiss actually is, why its name is so easily confused with two other products, and exactly how far the published evidence goes.
In one paragraph
Oligio Kiss is a lifting device made in South Korea by Wontech. It combines two previously separate machines in a single unit: the monopolar radiofrequency platform Oligio and the high-intensity focused ultrasound (HIFU) platform Ultraskin Tightan. Its approved name with Korea's Ministry of Food and Drug Safety is “The Great RF Sonata,” cleared on 1 September 2023; “Oligio Kiss” is the name it is sold and discussed under. It launched in Korea in February 2024.
At a glance
| Category | Combined RF and HIFU lifting device |
|---|---|
| Manufacturer | Wontech, South Korea |
| MFDS approved name | The Great RF Sonata — cleared 1 September 2023 |
| Market name | Oligio Kiss · launched in Korea February 2024 |
| Composition | Monopolar RF (Oligio) + focused ultrasound (Ultraskin Tightan) |
| Manufacturer's stated advantage | Both modalities delivered in one sitting without changing machines |
| Targets | Skin firmness and thickness; tightening of a softening contour |
| Does not treat | Volume loss, genuinely redundant skin, pigment, redness, acne scarring |
| Published trial data on this device | None found — see “How far the evidence goes” below |
The names first, because they are genuinely confusing
Oligio, Oligio X and Oligio Kiss are three different products. They share a manufacturer and most of a name, and they are routinely written about as though they were one machine with three labels. They are not.
Oligio is a monopolar radiofrequency device. Oligio X is a separate product with dual-mode RF — it is not Oligio Kiss under another name. Oligio Kiss is the unit that fuses the Oligio RF platform with the Ultraskin Tightan focused-ultrasound platform. Put simply: Oligio X extends what the device does within radiofrequency, while Oligio Kiss adds a different kind of energy altogether. Those are different directions, not different grades of the same thing.
| Oligio | Oligio X | Oligio Kiss | |
|---|---|---|---|
| Energy | Monopolar RF | RF, dual mode | RF + focused ultrasound |
| What it is | A standalone RF platform | A separate model in the RF line | Two modalities in one unit |
What actually separates RF from HIFU
The two do not perform the same task by different means. They perform different tasks.
Radiofrequency passes electromagnetic energy through tissue. Tissue resists that current, and the resistance makes the tissue itself generate heat from within — nothing is heated from the outside in. In a monopolar configuration the current spreads widely as it travels, so a broad volume of dermis is warmed comparatively evenly. Collagen contracts as it heats, and remodelling follows over the subsequent weeks.
Focused ultrasound works on a different principle entirely. Sound waves are focused by a lens to converge at a single point. Until they reach that focus the energy is dispersed and the intervening tissue is largely unaffected; only at the focus does temperature rise sharply enough to create a tiny coagulation point. The treatment consists of laying rows of these points at regular spacing, and the depth of the focus is fixed by the cartridge in use. So the description is not “heats a region” but “places points at a chosen depth.”
That difference determines what each is good for. Broad warming favours skin thickness and overall firmness. Discrete points at depth favour pulling on structure that has descended.
| Radiofrequency | Focused ultrasound | |
|---|---|---|
| How heat arises | Electromagnetic — tissue resistance makes the tissue heat itself | Acoustic — energy converges at a focus and spikes there |
| Pattern of heating | A broad volume, comparatively even (bulk heating) | Discrete coagulation points laid in rows |
| Depth reached | Across the dermis, spreading as it travels | A specific depth fixed by the cartridge |
| Problems it addresses | Thinned skin, general loss of firmness, texture | Descent at a particular depth, a softening contour |
| Discomfort | Comparatively mild | Comparatively greater |
| In common | Both use heat to provoke a collagen response, and both show their change over weeks rather than immediately | |
Neither is an upgrade of the other. They cover different ground — and in practice, faces showing both thinning and descent at once are the common case, not the exception.
What “both in one machine” does and does not mean
This is the design rationale: RF and HIFU can be delivered in a single sitting without swapping devices. We should be clear that this is the manufacturer's stated advantage. Previously the same combination meant two machines — time lost moving equipment and changing settings, and two separate frames of reference that make matching the treated area between the two passes awkward.
An honest qualification belongs here. Doing both on one machine is not in itself a better outcome. It is a statement about workflow and consistency, and no comparative study we could find shows a combined unit outperforming the same two modalities delivered on separate devices. What determines the result is which face receives which energy, in what order and at what intensity — and that is decided by the clinician, not by the chassis.
Nor does “can” mean “always should.” For thin, reactive skin, putting both energies into the same face on the same day is sometimes the wrong plan. The real value of holding both is being able to use only as much as the face needs.
Who it suits, and who it does not
Worth considering
- Loss of firmness and descent occurring together — skin that has thinned while the jawline has also blurred
- Patients who have had repeated RF and feel that the deeper descent never changed
- Patients who have had HIFU alone and feel that the skin's own thickness and texture stayed the same
- Mild to moderate laxity, with realistic expectations about the scale of change
- An unwillingness to consider surgery, and no room in the calendar for real recovery time
Where this device alone will not get you there
- Genuinely redundant skin — past the point tightening can reach, excision is required, and that is surgery
- Hollowing of the cheeks or temples — heat does not create volume
- Pigment, redness or acne scarring — the province of other devices entirely
- Pregnancy, or active infection or inflammation at the treatment site
- Metal implants or implanted electrical devices in the treatment area — tell us before we begin
- Wanting one session to settle the matter — no non-surgical device can promise that
How far the evidence goes
On Oligio Kiss itself
Search the device name and the phrase “clinically proven” appears quickly. It should not. We found no published clinical trial data generated with Oligio Kiss itself. Regulatory clearance means the device passed a safety and performance review; it does not mean a trial was published. Accordingly this page makes no claim about a duration in months or a percentage of improvement for this device.
Class-level evidence — monopolar RF
Evidence does exist for the technology classes. We introduce it with the qualification stated first: this is not a study of Oligio Kiss.
On facial monopolar radiofrequency, a study published in Cosmetics 2024;11(3):71 followed 20 healthy women (mean age 47.95±6.02, Fitzpatrick III–IV, mild to moderate facial laxity) after a single treatment, with assessments at 4, 12 and 24 weeks. At 12 weeks there was statistically significant improvement in the jawline and nasolabial folds (p<0.05); cheek elasticity rose from week 4 (p<0.01) and was maintained to 24 weeks. Mean pain was 0.4 out of 10, and no burns or scarring were reported.
The numbers read well, and the limitations the authors themselves state have to be read with them. This was a prospective, evaluator-blinded cohort without a randomised control group; the participants were a small number of women only; and there was no comparison against other technologies. Without a control arm, the contribution of time itself cannot be separated out, and a cohort of twenty will not surface uncommon adverse events.
Class-level evidence — focused ultrasound
For focused ultrasound, a systematic review covering skin tightening and body contouring appears in Aesthetic Surgery Journal 2025;45(7):690 (doi 10.1093/asj/sjaf053). We have not read the full text, so we quote no figures and no conclusions from it and record only that the review exists. Guessing at what a paper concluded is not something we are willing to do in a clinical reference.
To summarise: both technologies have long track records as classes, with a literature to match. That literature does not establish the performance of one particular machine, because output characteristics and delivery differ between devices. The position this page takes is to cite class-level evidence as class-level evidence and not transcribe it into claims about a named device.
What the appointment involves
The consultation starts by naming the dominant problem: is it that the skin has thinned and lost firmness, is it that deeper structure has descended and blurred the contour, or is it both? That judgement decides whether RF is used alone, whether HIFU is added, and where the emphasis falls.
After cleansing, topical anaesthetic is applied where appropriate and guide lines are drawn on the treatment area to map coverage and direction. The plan for working against the direction of descent is set at this stage.
For the RF pass, gel is applied and the handpiece is kept in contact with the skin and moved across it; warmth builds and fades, repeatedly. For the HIFU pass, the cartridge is held in contact and fired line by line along the mapped rows, with a brief sharp sensation at each point. Where both are used, their order and intensity are adjusted against what the skin is doing on the day. Treatment time varies with the area covered; we will give you a figure at consultation.
Timeline
-
Day 0Redness and warmthTreated areas may look flushed and feel hot. Some patients report an immediate tightened feel; it mixes prompt collagen contraction with swelling, so it is not the change that will last.
-
Day 1–3Swelling and tenderness to pressureRedness usually settles within a day. Where HIFU was included, an ache on pressing the face or on chewing can linger for several days.
-
Week 2–4The response is under wayCollagen that responded to heat is remodelling. Visible change is often still indistinct at this stage.
-
Month 2–3Review pointWe assess the actual change here and discuss whether anything further is warranted. In the monopolar RF study cited above, significant improvement was recorded at 12 weeks.
-
BeyondObservationNo published data exist on how long results from this device last, so we do not quote a number of months. Maintenance is decided on what we observe.
Discomfort, downtime and adverse effects
On pain, plainly: HIFU is more uncomfortable than RF. Radiofrequency registers mostly as heat building and receding; focused ultrasound produces a brief sharp or aching sensation each time a coagulation point is formed. A treatment using both is therefore more demanding than an RF-only session. The mean pain of 0.4/10 in the study cited above describes RF alone and does not transfer to a session that includes HIFU. Pain thresholds also vary widely between people.
Downtime is generally short. Redness and mild swelling are the usual reactions, and most patients return to normal activity the same day. Please observe the following.
- No sauna, jjimjilbang, hot baths, strenuous exercise or alcohol on the day
- Cleanse gently with lukewarm water; do not rub the treated area
- Sun protection more diligently than usual, and moisturise well
- Pause exfoliation and facial massage for the time being
Common questions
Are Oligio, Oligio X and Oligio Kiss the same thing?
Which is better, RF or HIFU?
Is one combined machine better than two separate ones?
Is this device clinically proven?
Does it hurt?
How many sessions, and how long does it last?
How does it compare with other lifting devices?
What does it cost?
About the authoring clinic
This reference was written and reviewed by Dr. Lee Chi-Hak, director of Miso Clinic in Daegu, South Korea. The clinic holds lifting devices that work by genuinely different mechanisms alongside the injectable classes, and selects between them according to the kind of change a face is actually showing. Our other device references are X-erF and Density; the injectables are compared in six collagen boosters; the full list is in the Miso Clinic reference library.
| Director | Dr. Lee Chi-Hak |
|---|---|
| Address | 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, South Korea · Exit 1, Kyungpook National University Hospital Station |
| Telephone | +82 53-428-2700 |
| KakaoTalk | Miso Clinic channel |
| Hours | Weekdays 11:00–19:00 (lunch 13:00–14:00) / Saturday 10:00–16:00 (no lunch break) / Closed Sundays and public holidays |
| Website | clinicmiso.co.kr |
| Reference library | Miso Clinic reference library |
| 한국어 | 올리지오 키스 진료 자료 (Korean) |
References
- Korean Ministry of Food and Drug Safety, medical device approval record — The Great RF Sonata (Wontech), cleared 1 September 2023. Marketed as “Oligio Kiss.”
- Wontech product information — composition (monopolar RF Oligio + focused ultrasound Ultraskin Tightan), Korean launch February 2024, and the manufacturer's statement that both modalities can be delivered consecutively without changing devices.
- Suh D·H et al. Efficacy and Safety of Monopolar Radiofrequency for Tightening the Skin of Aged Faces. Cosmetics 2024;11(3):71 — prospective, evaluator-blinded cohort study of facial monopolar radiofrequency. 20 healthy women (mean 47.95±6.02 years, Fitzpatrick III–IV, mild to moderate laxity), single treatment, assessed at 4, 12 and 24 weeks. Significant improvement in jawline and nasolabial folds at 12 weeks (p<0.05); cheek elasticity increased from week 4 (p<0.01) and was maintained to 24 weeks. Mean pain 0.4/10; no burns or scarring reported. Limitations stated by the authors: no randomised control group, a small female-only sample, and no comparison with other technologies. This is class-level evidence for monopolar RF, not a study of Oligio Kiss.
- Aesthetic Surgery Journal 2025;45(7):690 (doi 10.1093/asj/sjaf053) — systematic review of focused ultrasound for skin tightening and body contouring. We have not read the full text and therefore quote no figures or conclusions from it. A class-level review, not a study of Oligio Kiss.
- Miso Clinic protocol — criteria for selecting energy class, coverage planning by facial region, and informed-consent procedure.
This page provides general information about an aesthetic treatment and does not substitute for medical diagnosis or care. Outcomes and adverse effects vary with individual skin condition, age and underlying illness, and no result is guaranteed. Decisions about treatment should be made in an in-person consultation with a qualified clinician.